
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$62.43
+$0.22 · +0.35%
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Regular session
$62.43
+$0.22 · +0.35%
Regular session · ET · Market data may be delayed.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Day range
Current $62.43
52-week range
Current $62.43
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
99
Deep Value
Sentiment
53
Mixed
Risk
40
Moderate Risk
Momentum
79
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Day range
Current $62.43
52-week range
Current $62.43
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 77.55M USD | 66.59M USD | 53.84M USD | 46.09M USD | 42.04M USD |
| Cost of goods sold | 53.21M USD | 47.08M USD | 39.29M USD | 33.34M USD | 28.91M USD |
| Gross profit | 24.34M USD | 19.51M USD | 14.55M USD | 12.75M USD | 13.13M USD |
| Research and development | 3.35M USD | 3.64M USD | 3.19M USD | 2.8M USD | 2.98M USD |
| Selling, general, and administrative | 8M USD | 5.19M USD | 4.19M USD | 4.18M USD | 4.99M USD |
| Operating expenses | 11.34M USD | 8.82M USD | 7.38M USD | 6.99M USD | 8.01M USD |
| Interest income | 181K USD | 82K USD | 144K USD | 294K USD | 76K USD |
| Interest expense | 812K USD | 829K USD | 558K USD | 533K USD | 464K USD |
| Depreciation and amortization | 1.39M USD | 1.24M USD | 1.16M USD | 857K USD | 726K USD |
| Operating income | 12.99M USD | 10.69M USD | 7.17M USD | 5.76M USD | 5.12M USD |
| Net income | 13.66M USD | 8.98M USD | 2.13M USD | 7.07M USD | 4.57M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 18, 2010 | 1:3 | — | — |
Effective Jun 18, 2010
1:3
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM3.66M0.00%77.7B USD0.19%$277.95+0.14%
Vanguard Morningstar Total Stock Market ETFVTI3.47M0.00%2.3T USD0.03%$380.88+0.35%
Dimensional - US Small Cap ETFDFAS1.93M0.01%33.8B USD0.31%$78.195+0.12%
Vanguard Extended Market ETFVXF1.3M0.00%95.4B USD0.05%$233.97+0.36%
iShares Russell 2000 Growth ETFIWO1.15M0.01%14.04B USD0.24%$354.77+0.37%
Vanguard Russell 2000 ETFVTWO737.69K0.00%18B USD0.06%$112.27+0.15%
Dimensional - US Core Equity 2 ETFDFAC481.74K0.00%88.2B USD0.21%$45.215+0.23%
First Trust Dow Jones Select MicroCap Index FundFDM470.18K0.18%260.47M USD0.65%$88.66-0.44%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Dimensional - US Small Cap ETFDFAS
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
Dimensional - US Core Equity 2 ETFDFAC
First Trust Dow Jones Select MicroCap Index FundFDMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.